Olaris: Strategic Investment Raised From Labcorp
By Amit Chowdhry ● Apr 11, 2025
Olaris, a precision medicine company leveraging metabolomics and machine learning to discover and develop its myOLARIS diagnostics products, announced an investment from Labcorp, a leader of innovative and comprehensive laboratory services, as part of its Series-B1 financing. Labcorp joins existing investors Robert Carpenter, Innospark Ventures, North Point Partners, Alumni Ventures, and new investor US Boston Growth Capital.